ABSTRACT
Solitary or multiple cutaneous leiomyomas are benign tumors derived from vascular, areolar, dartos, or pilar smooth muscle fibers (Holst et al., 2002), which can be part of a syndrome when associated with MCUL (Garman et al., 2003). Furthermore, 15–62% of MCUL patients may develop a papillary renal type II or renal duct cancer HLRCC configuring a more complex entity (MCUL/HLRCC, OMIM 150800) (Toro, 2003). This syndrome is due to heterozygous mutations in the FH gene (Kiuru et al., 2001; Tomlinson et al., 2002), which acts as a tumor-suppressor gene to protect cells from hypoxic stress (Pollard, 2005). Homozygous mutations cause a complete FHD syndrome (FHD; OMIM 606812), which is lethal in childhood (Bourgeron et al., 1994). FH enzymatic activity is absent in FHD, reduced by nearly 50% in MCUL/HLRCC, and very low or absent in tumors from MCUL patients (Tomlinson et al., 2002), suggesting loss of heterozygosity. Besides FH, a number of different Krebs cycle genes have also been found to be mutated in neoplasms, such as SDH in paraganglioma and pheochromocytoma (Baysal, 2000; Niemann and Muller, 2000); or in neo or hyper vascular conditions such as in VHL syndrome (Kim and Kaelin, 2004).
REFERENCES
Baysal BE (2000) Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287:848Bourgeron T, Chretien D, Poggi-Bach J, Doonan S, Rabier D, Letouze P et al. (1994) Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. J Clin Invest 93:2514–8
Garman ME, Blumberg MA, Ernst R, Raimer SS (2003) Familial leiomyomatosis: a review and discussion of pathogenesis. Dermatology 207:210–3
Hatch MD (1978) A simple spectrophotometric assay for fumarate hydratase in crude tissue extracts. Anal Biochem 85:271–5
Holst VA, Junkins-Hopkins JM, Elenitsas R (2002) Cutaneous smooth muscle neoplasms: clinical features, histologic findings, and treatment options. J Am Acad Dermatol 46:477–90; quiz, 491–474
Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22:4991
Kiuru M, Launonen V, Hietala M, Aittomaki K, Vierimaa O, Salovaara R et al. (2001) Familial cutaneous leiomyomatosis is a twohit condition associated with renal cell cancer of characteristic histopathology. Am J Pathol 159:825–9
Niemann S, Muller U (2000) Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 26:268–70
Pollard PJ (2005) Accumulation of Krebs cycle intermediates and over-expression of HIF1[alpha] in tumors which result from germline FH and SDH mutations. Hum Mol Genet 14:2231
Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D et al. (2002) Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata, and papillary renal cell cancer. Nat Genet 30:406–10
Toro JR (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95